Making an impact in Africa
Amadou Gueye, Sub-saharan Market Development Manager for QIAGEN
Taking the situation as it is
In other parts of the world, similar maintenance services are completed via the technical hotline instead of in person. In Africa the culture is different: “You turn to the people you know here”, says Gueye from his native Senegal. That's why he's willing to play contact person for his African customers even if it means his mobile phone never seems to stop ringing.
On this trip to Uganda, he has also managed to set up a consultation with the managers of the national tuberculosis program. “My goal for the next five years,” Gueye says, “is to establish our TB solutions as the standard of care for latent TB diagnosis on the African continent.”
70 cities in 10 months
Every two weeks Gueye flies back and forth between his home in Paris and the African continent – he’s been to 70 cities in the past 10 months alone. Every time Gueye gets on a plane, his 10-year-old son pushes a thumbtack into a world map to mark his father’s next destination. “I explain to my kids that I help doctors in Africa to help people.”
For his job at QIAGEN, he is happy to travel to places “where nobody else wants to go,” knowing it makes a positive impact on the people there. Recently, he spent two days traveling to a refugee camp in Makere, Tanzania, where he helped reestablish the testing process for latent TB infection using QuantiFERON. “It was one of my most memorable experiences in this job,” he reflects.
Avoiding repeat hospital visits with syndromic testingSyndromic testing with QIAstat-Dx ensures fast results for senior patients who cannot afford to wait for a diagnoses.
Tuberculosis diagnosis turns patients into advocatesOver a decade ago, the Halsteads returned from their honeymoon with an infection known to kill 1.5 million people a year globally and learned how to overcome the disease.
Analyzing the ancient origins of rare genetic diseasesEsteemed geneticist, Dr. Bisgin, uses QIAGEN bioinformatic tools to help find a cure for rare genetic diseases in Turkey.